Related Experiment Video
Updated: Jun 21, 2025

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade
Published on: August 14, 2019
Flavonoids: Potential therapeutic agents for cardiovascular disease
Yingxue Liu1, Jing Luo1, Lin Peng2
1Department of Cardiology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Flavonoids, natural plant compounds, show promise for cardiovascular health by acting as antioxidants and reducing inflammation. Their diverse effects offer potential therapeutic benefits for conditions like hypertension and atherosclerosis.
Area of Science:
- Plant biochemistry and pharmacology
- Cardiovascular medicine
- Molecular biology
Background:
- Flavonoids are ubiquitous plant compounds involved in growth, development, and stress response.
- They possess antioxidant and anti-inflammatory properties relevant to cardiovascular health.
- Emerging evidence highlights their therapeutic potential for cardiovascular diseases.
Purpose of the Study:
- To review the role and mechanisms of flavonoids in cardiovascular diseases.
- To explore the clinical applications of flavonoids in managing cardiovascular conditions.
- To provide a reference for future clinical use of flavonoids.
Main Methods:
- Literature review of studies on flavonoid mechanisms in cardiovascular disease.
- Analysis of flavonoid effects on inflammatory pathways (e.g., TLR4-NF-ĸB, PI3K-AKT, Nrf2/HO-1).
- Examination of flavonoid impact on blood pressure regulation and myocardial function.
Main Results:
- Flavonoids modulate key inflammatory signaling pathways.
- They influence endothelium-dependent and independent blood pressure regulation.
- Flavonoids impact myocardial contractility via calcium homeostasis and protein expression.
Conclusions:
- Flavonoids exhibit multifaceted therapeutic potential for cardiovascular diseases.
- Their antioxidant, anti-inflammatory, and other properties are crucial for cardiovascular protection.
- Further clinical research is warranted to fully leverage flavonoid-based therapies.
More Related Videos
12:00Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
Published on: July 5, 2017
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Antihypertensive Drugs: Vasodilators
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...